The growing incidence of myeloproliferative disorders is augmenting the growth of the m... - 0 views
-
ajinkyak on 01 Jul 21The growing incidence of myeloproliferative disorders around the globe due to the increasing geriatric population is propelling the growth of the myeloproliferative neoplasms treatment market. John Wiley & Sons, Inc., reported annual incidence rates ranged from 0.01 to 2.61, 0.21 to 2.27, and 0.22 to 0.99 per 100,000 for PV, ET, and PMF, respectively.